About me
Julie Kim, president of Takeda’s U.S. Business Unit and U.S. country head, oversees a portfolio of gastroenterology, neuroscience, plasma-derived therapies and rare diseases. With 30 years in healthcare, she’s held leadership roles across therapeutic areas, market access, general management, marketing. Recognized as Boston Magazine’s 150 Most Influential Bostonians (2024), 2024 Pinnacle Award honoree and 2023 Boston’s 50 Most Influential AAPIs (2023).
